JT
ALXN

Jump Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Jump Trading’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,300
Closed -$502K – 615
2016
Q2 		$502K Buy
+4,300
New +$610K 0.02% 412
2015
Q3 		– Sell
-2,600
Closed -$470K – 1104
2015
Q2 		$470K Buy
+2,600
New +$449K 0.01% 486
2014
Q4 		– Sell
-200
Closed -$33K – 1255
2014
Q3 		$33K Buy
+200
New +$32.8K ﹤0.01% 948

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Jump Trading's ALXN Position: Q1 2016 in Review

Jump Trading sold out of Alexion Pharmaceuticals (ALXN) in Q1 2016, closing a stake of 1,149 shares — an estimated $219K sold.

Jump Trading first reported a position in ALXN in Q3 2014 and held it in 2 quarters. The position peaked at $1.11M in Q3 2014. 520 funds tracked by Wall St. Rank hold ALXN as of Q1 2016.

  • Jump Trading reported no remaining Alexion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Jump Trading sold 1,149 Alexion Pharmaceuticals shares in Q1 2016, an estimated $219K.
  • Jump Trading first reported a position in Alexion Pharmaceuticals in Q3 2014 and held it in 2 quarters.
  • Jump Trading's Alexion Pharmaceuticals position peaked at $1.11M in Q3 2014.
  • 520 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2016.

Based on Jump Trading's 13F filing for Q1 2016, filed 17 May 2016.